Cargando…

Current State and Principles of Basal Insulin Therapy in Type 2 Diabetes

Treatment with basal insulins is a fundamental part of management in many patients with type 2 diabetes mellitus. Multiple management schemes may be indicated in these individuals, for example, the use of oral antihyperglycemic agents with basal insulins (basal-supported oral therapy) or the combina...

Descripción completa

Detalles Bibliográficos
Autor principal:	Vargas-Uricoechea, Hernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827224/ https://www.ncbi.nlm.nih.gov/pubmed/35211212 http://dx.doi.org/10.14740/jocmr4660

Ejemplares similares

Fixed-Ratio combinations (Basal Insulin Plus GLP-1RA) in Type 2 diabetes. An analytical review of pivotal clinical trials
por: Vargas-Uricoechea, Hernando, et al.
Publicado: (2023)

Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
por: Vargas-Uricoechea, Hernando
Publicado: (2018)

Control of Blood Pressure and Cardiovascular Outcomes in Type 2 Diabetes
por: Vargas-Uricoechea, Hernando, et al.
Publicado: (2018)

Molecular Mechanisms in Autoimmune Thyroid Disease
por: Vargas-Uricoechea, Hernando
Publicado: (2023)

Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study
por: Galstyan, Gagik R., et al.
Publicado: (2022)

How pharmacokinetic and pharmacodynamic principles pave the way for optimal basal insulin therapy in type 2 diabetes
por: Arnolds, S, et al.
Publicado: (2010)

Real‐world effectiveness and safety of insulin glargine 300 U/ml in insulin‐naïve people with type 2 diabetes in the Latin America region: A subgroup analysis of the ATOS
por: Vargas‐Uricoechea, Hernando, et al.
Publicado: (2022)

Population Status of Vitamin B12 Values in the General Population and in Individuals with Type 2 Diabetes, in Southwestern Colombia
por: Vargas-Uricoechea, Hernando, et al.
Publicado: (2023)

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau, Ip Tim, et al.
Publicado: (2017)

Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
por: Abrahamson, Martin J., et al.
Publicado: (2012)

Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
por: Moreira, Rodrigo Oliveira, et al.
Publicado: (2018)

Detemir as a once-daily basal insulin in type 2 diabetes
por: Nelson, Scott E
Publicado: (2011)

Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review
por: Meece, Jerry
Publicado: (2018)

Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes
por: Mehta, Roopa, et al.
Publicado: (2022)

Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist
por: Patel, Dhiren, et al.
Publicado: (2019)

Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
por: Ahmann, Andrew
Publicado: (2015)

Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
por: Kalirai, Samaneh, et al.
Publicado: (2020)

A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
por: Forst, Thomas, et al.
Publicado: (2020)

A practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes
por: Edelman, Steven, et al.
Publicado: (2007)

Case Study: Remission of Type 2 Diabetes After Outpatient Basal Insulin Therapy
por: Schmidt, Sierra C., et al.
Publicado: (2016)

Combination Therapy With Premixed & Basal Insulin Analogues in Asian Indians With Type 2 Diabetes
por: Srivastava, Brijendra Kumar, et al.
Publicado: (2021)

Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
por: Bajaj, Harpreet S, et al.
Publicado: (2023)

Lixisenatide as add-on therapy to basal insulin
por: Brown, Dominique Xavier, et al.
Publicado: (2013)

Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
por: Heller, Simon, et al.
Publicado: (2023)

The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes
por: Retnakaran, Ravi, et al.
Publicado: (2023)

Review of basal‐plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus
por: Raccah, D., et al.
Publicado: (2017)

The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease
por: Vargas-Uricoechea, Hernando, et al.
Publicado: (2023)

Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
por: Pfohl, Martin, et al.
Publicado: (2015)

Stepwise intensification of insulin therapy in Type 2 diabetes management—exploring the concept of the basal-plus approach in clinical practice
por: Owens, D R
Publicado: (2013)

Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study
por: Bellido, Diego, et al.
Publicado: (2018)

Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment
por: Tien, Kai‐Jen, et al.
Publicado: (2019)

A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
por: Candido, Riccardo, et al.
Publicado: (2018)

Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
por: Berard, Lori, et al.
Publicado: (2018)

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin
por: Khunti, K., et al.
Publicado: (2016)

Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus
por: Chien, Ming‐Nan, et al.
Publicado: (2016)

Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes
por: Ericsson, Åsa, et al.
Publicado: (2018)

Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus
por: Zhang, Puhong, et al.
Publicado: (2020)

Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
por: Handelsman, Yehuda, et al.
Publicado: (2019)

An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes
por: Lingvay, Ildiko, et al.
Publicado: (2022)

The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy
por: Ozturkmen, Yuksel Asli, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j0kt1am0mtqh3617rd307icdnc